1. Endo thinks it has the financial flexibility to weather the storm of opioid settlements — Takeda acquires celiac-focused PvP Biologics — Iovance jumps on buyout rumors — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Abbott IT


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    13
    Views:
    2,865
  2. anonymous
    Replies:
    2
    Views:
    1,735
  3. anonymous
    Replies:
    2
    Views:
    3,505
  4. Anonymous
    Replies:
    12
    Views:
    13,036
  5. Anonymous
    Replies:
    0
    Views:
    2,393
  6. Anonymous
    Replies:
    3
    Views:
    5,554
  7. Anonymous
    Replies:
    0
    Views:
    4,287

Thread Display Options

Loading...